Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

No effect of escitalopram versus placebo on brain-derived neurotrophic factor in healthy individuals: a randomised trial

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Markers of HPA-axis activity and nucleic acid damage from oxidation after electroconvulsive stimulations in rats

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Selective serotonin reuptake inhibitors are still harmful and ineffective. Responses to the comments by Hieronymus et al

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Differential plastic changes in synthesis and binding in the mouse somatostatin system after electroconvulsive stimulation

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Effects of erythropoietin on body composition and fat-glucose metabolism in patients with affective disorders

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Hypomania/Mania by DSM-5 definition based on daily smartphone-based patient-reported assessments

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Transcranial pulsed electromagnetic fields for treatment-resistant depression: A multicenter 8-week single-arm cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVE: Brain-derived neurotrophic factor (BDNF) seems to play an important role in the course of depression including the response to antidepressants in patients with depression. We aimed to study the effect of an antidepressant intervention on peripheral BDNF in healthy individuals with a family history of depression.

METHODS: We measured changes in BDNF messenger RNA (mRNA) expression and whole-blood BDNF levels in 80 healthy first-degree relatives of patients with depression randomly allocated to receive daily tablets of escitalopram 10 mg versus placebo for 4 weeks.

RESULTS: We found no statistically significant difference between the escitalopram and the placebo group in the change in BDNF mRNA expression and whole-blood BDNF levels. Post hoc analyses showed a statistically significant negative correlation between plasma escitalopram concentration and change in whole-blood BDNF levels in the escitalopram-treated group.

CONCLUSION: The results of this randomised trial suggest that escitalopram 10 mg has no effect on peripheral BDNF levels in healthy individuals.

Original languageEnglish
JournalActa Neuropsychiatrica
Volume2
Pages (from-to)101-9
Number of pages9
ISSN1601-5215
DOIs
Publication statusPublished - 2016

ID: 45806621